News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
Search Query
Submit Search
Eisai Company, Ltd. Introduces Rx-to-OTC Switch Product For Allergy-related Rhinitis And Skin Problems
October 31, 2006
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Tokyo, Oct 31, 2006 (JCN) - Eisai has introduced a Rx-to-OTC switch product for allergic-related rhinitis and skin problems, available from November 1.
Twitter
LinkedIn
Facebook
Email
Print
Asia
MORE ON THIS TOPIC
Startups
Harbour Cofunds Cancer Startup, Hands Off Clinical-Stage Antibody
February 25, 2026
·
2 min read
·
Tristan Manalac
GLP-1
Pfizer Builds Global GLP-1 Strategy With up to $495M Sciwind Deal
February 24, 2026
·
2 min read
·
Tristan Manalac
Obesity
Kailera, Hengrui Push Oral GLP-1/GIP Pill to Phase 3 After Clearing Mid-Stage China Study
February 10, 2026
·
1 min read
·
Tristan Manalac
China
Clinical Trials Are Increasingly Going Global—With China a Main Beneficiary
February 2, 2026
·
8 min read
·
Annalee Armstrong
